| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocarditis | 27 | 2018 | 804 | 1.850 |
Why?
|
| Heart Transplantation | 39 | 2021 | 3291 | 1.580 |
Why?
|
| Cardiomyopathy, Dilated | 24 | 2015 | 843 | 1.550 |
Why?
|
| Heart Failure | 59 | 2023 | 11857 | 1.440 |
Why?
|
| Cardiomyopathy, Restrictive | 3 | 2018 | 61 | 1.190 |
Why?
|
| Myocardium | 31 | 2023 | 4788 | 1.010 |
Why?
|
| Cardiovascular Agents | 4 | 2019 | 849 | 1.000 |
Why?
|
| Cardiomyopathies | 14 | 2023 | 2056 | 0.850 |
Why?
|
| Defibrillators, Implantable | 6 | 2018 | 1498 | 0.640 |
Why?
|
| Endocardium | 10 | 2016 | 249 | 0.610 |
Why?
|
| Cardiac Resynchronization Therapy | 5 | 2015 | 559 | 0.600 |
Why?
|
| Pheochromocytoma | 2 | 2009 | 328 | 0.570 |
Why?
|
| Disease Management | 2 | 2018 | 2533 | 0.560 |
Why?
|
| Cardiology | 5 | 2023 | 1701 | 0.550 |
Why?
|
| Graft Rejection | 10 | 2021 | 4505 | 0.520 |
Why?
|
| Pulmonary Edema | 3 | 2009 | 409 | 0.490 |
Why?
|
| Enalapril | 2 | 2015 | 316 | 0.470 |
Why?
|
| Cardiotonic Agents | 4 | 2008 | 544 | 0.460 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2009 | 736 | 0.460 |
Why?
|
| Biopsy | 19 | 2016 | 6816 | 0.450 |
Why?
|
| Metanephrine | 2 | 2009 | 25 | 0.430 |
Why?
|
| Virus Diseases | 3 | 2015 | 723 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 11 | 2014 | 2145 | 0.420 |
Why?
|
| Pregnancy Complications | 3 | 2010 | 2969 | 0.380 |
Why?
|
| Electrocardiography | 11 | 2018 | 6410 | 0.370 |
Why?
|
| Puerperal Disorders | 2 | 2011 | 303 | 0.350 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2013 | 271 | 0.340 |
Why?
|
| Maltose | 1 | 2009 | 39 | 0.340 |
Why?
|
| Adrenergic beta-Antagonists | 6 | 2017 | 1244 | 0.330 |
Why?
|
| Tetrazoles | 1 | 2015 | 922 | 0.330 |
Why?
|
| Ultrafiltration | 1 | 2009 | 48 | 0.330 |
Why?
|
| Stroke Volume | 24 | 2014 | 5620 | 0.320 |
Why?
|
| Etiocholanolone | 1 | 2008 | 7 | 0.310 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2009 | 152 | 0.300 |
Why?
|
| Ferric Compounds | 1 | 2009 | 379 | 0.290 |
Why?
|
| Steroids | 1 | 2013 | 937 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 7451 | 0.280 |
Why?
|
| Hematinics | 1 | 2009 | 282 | 0.270 |
Why?
|
| Foramen Ovale, Patent | 3 | 2013 | 210 | 0.260 |
Why?
|
| Digoxin | 2 | 2007 | 246 | 0.260 |
Why?
|
| Humans | 158 | 2023 | 768451 | 0.260 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 373 | 0.250 |
Why?
|
| Ventricular Function, Left | 17 | 2017 | 3941 | 0.250 |
Why?
|
| Dobutamine | 1 | 2005 | 116 | 0.240 |
Why?
|
| Milrinone | 1 | 2005 | 86 | 0.240 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2007 | 881 | 0.230 |
Why?
|
| Nitroglycerin | 1 | 2005 | 332 | 0.230 |
Why?
|
| Exercise Test | 8 | 2003 | 2186 | 0.220 |
Why?
|
| Electric Countershock | 1 | 2006 | 534 | 0.210 |
Why?
|
| Anemia | 2 | 2015 | 1521 | 0.200 |
Why?
|
| Sex Factors | 4 | 2014 | 10647 | 0.200 |
Why?
|
| Giant Cells | 4 | 2018 | 188 | 0.200 |
Why?
|
| Terminology as Topic | 3 | 2014 | 1539 | 0.200 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 118 | 0.200 |
Why?
|
| Propanolamines | 2 | 2001 | 164 | 0.200 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 5887 | 0.190 |
Why?
|
| Echocardiography | 11 | 2019 | 5043 | 0.190 |
Why?
|
| Exercise Tolerance | 3 | 1997 | 849 | 0.190 |
Why?
|
| Acute Disease | 9 | 2014 | 7246 | 0.180 |
Why?
|
| Dyspnea | 3 | 2009 | 1352 | 0.180 |
Why?
|
| Immunosuppressive Agents | 11 | 2008 | 4213 | 0.180 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2001 | 115 | 0.170 |
Why?
|
| Male | 98 | 2023 | 364781 | 0.170 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1444 | 0.170 |
Why?
|
| Glomerulonephritis | 1 | 2002 | 333 | 0.170 |
Why?
|
| Coronary Angiography | 7 | 2015 | 4526 | 0.170 |
Why?
|
| Female | 96 | 2023 | 396943 | 0.170 |
Why?
|
| Vasodilator Agents | 6 | 2007 | 991 | 0.160 |
Why?
|
| Myosins | 6 | 2006 | 409 | 0.160 |
Why?
|
| Carbazoles | 1 | 2001 | 221 | 0.160 |
Why?
|
| Indium Radioisotopes | 6 | 2006 | 116 | 0.160 |
Why?
|
| Catecholamines | 2 | 2010 | 390 | 0.160 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2007 | 1568 | 0.160 |
Why?
|
| Lymphatic Diseases | 1 | 2000 | 320 | 0.150 |
Why?
|
| Amyloidosis | 2 | 2018 | 879 | 0.150 |
Why?
|
| Fetal Death | 2 | 2009 | 438 | 0.150 |
Why?
|
| Myocardial Contraction | 11 | 2004 | 1527 | 0.140 |
Why?
|
| Oxygen Consumption | 6 | 1998 | 1882 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2015 | 24311 | 0.140 |
Why?
|
| Speech Production Measurement | 1 | 2017 | 99 | 0.140 |
Why?
|
| Heart Conduction System | 1 | 2003 | 1009 | 0.140 |
Why?
|
| Thoracic Surgery | 1 | 2004 | 727 | 0.140 |
Why?
|
| Microvessels | 1 | 2021 | 586 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2020 | 367 | 0.140 |
Why?
|
| Breathing Exercises | 1 | 1997 | 59 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2017 | 52 | 0.140 |
Why?
|
| Hemodynamics | 15 | 2012 | 4202 | 0.140 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2009 | 583 | 0.140 |
Why?
|
| Middle Aged | 79 | 2019 | 223418 | 0.140 |
Why?
|
| Pleural Effusion | 1 | 2000 | 344 | 0.140 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 1035 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2021 | 550 | 0.140 |
Why?
|
| Waiting Lists | 2 | 2002 | 778 | 0.140 |
Why?
|
| Cardiac Volume | 1 | 1997 | 197 | 0.140 |
Why?
|
| Muromonab-CD3 | 4 | 2008 | 104 | 0.140 |
Why?
|
| Speech Acoustics | 1 | 2017 | 155 | 0.140 |
Why?
|
| Sarcoidosis | 2 | 2018 | 539 | 0.140 |
Why?
|
| Heart Diseases | 3 | 2014 | 2816 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2005 | 1751 | 0.130 |
Why?
|
| Diagnosis, Differential | 11 | 2018 | 13026 | 0.130 |
Why?
|
| Acoustics | 1 | 2017 | 244 | 0.130 |
Why?
|
| Phonation | 1 | 2017 | 220 | 0.130 |
Why?
|
| Heart Rate | 8 | 2010 | 4218 | 0.130 |
Why?
|
| Certification | 1 | 2019 | 419 | 0.130 |
Why?
|
| Recovery of Function | 4 | 2017 | 2994 | 0.130 |
Why?
|
| Voice Quality | 1 | 2017 | 226 | 0.130 |
Why?
|
| Prognosis | 18 | 2015 | 30028 | 0.130 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 135 | 0.130 |
Why?
|
| Educational Measurement | 2 | 2019 | 1256 | 0.120 |
Why?
|
| Coronary Vessels | 4 | 2023 | 3122 | 0.120 |
Why?
|
| Heparin | 1 | 2002 | 1636 | 0.120 |
Why?
|
| Ventricular Function, Right | 3 | 2003 | 629 | 0.120 |
Why?
|
| Treatment Outcome | 22 | 2017 | 65409 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 2 | 2018 | 1309 | 0.120 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 3543 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2002 | 1183 | 0.120 |
Why?
|
| Awareness | 1 | 1998 | 654 | 0.110 |
Why?
|
| Survival Rate | 10 | 2015 | 12875 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 829 | 0.110 |
Why?
|
| Voice Disorders | 1 | 2017 | 286 | 0.110 |
Why?
|
| Adult | 51 | 2019 | 223542 | 0.110 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2014 | 109 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 1320 | 0.110 |
Why?
|
| Enoximone | 1 | 1993 | 9 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 4 | 2014 | 1605 | 0.110 |
Why?
|
| Edema | 1 | 2017 | 766 | 0.110 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2014 | 97 | 0.110 |
Why?
|
| Complement C4b | 2 | 2005 | 125 | 0.110 |
Why?
|
| Vocal Cords | 1 | 2017 | 520 | 0.110 |
Why?
|
| Disease-Free Survival | 7 | 2014 | 6856 | 0.110 |
Why?
|
| Nitric Oxide | 5 | 2005 | 2146 | 0.100 |
Why?
|
| Diuretics | 3 | 2017 | 612 | 0.100 |
Why?
|
| Ventricular Function | 1 | 1994 | 406 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2013 | 289 | 0.100 |
Why?
|
| Cardiovascular Diseases | 4 | 2013 | 15638 | 0.100 |
Why?
|
| Coronary Disease | 4 | 2002 | 5926 | 0.100 |
Why?
|
| Internal Medicine | 1 | 2019 | 1056 | 0.100 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 141 | 0.100 |
Why?
|
| Time Factors | 13 | 2014 | 40271 | 0.090 |
Why?
|
| Heart | 7 | 2023 | 4451 | 0.090 |
Why?
|
| Heart Ventricles | 7 | 2012 | 3839 | 0.090 |
Why?
|
| Myocardial Infarction | 7 | 2014 | 11515 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2001 | 2731 | 0.090 |
Why?
|
| Tachycardia | 2 | 2009 | 599 | 0.090 |
Why?
|
| Walking | 2 | 1997 | 1202 | 0.090 |
Why?
|
| Heart-Assist Devices | 3 | 2014 | 1292 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 36840 | 0.090 |
Why?
|
| Diastole | 6 | 2011 | 784 | 0.090 |
Why?
|
| Clinical Competence | 3 | 2023 | 4841 | 0.090 |
Why?
|
| Pre-Eclampsia | 2 | 2009 | 1257 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 2 | 1996 | 839 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 3708 | 0.080 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 153 | 0.080 |
Why?
|
| Cyclosporine | 3 | 2008 | 780 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.080 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2010 | 122 | 0.080 |
Why?
|
| Follow-Up Studies | 18 | 2017 | 39430 | 0.080 |
Why?
|
| Syndrome | 2 | 2006 | 3278 | 0.080 |
Why?
|
| Rectum | 1 | 2014 | 902 | 0.080 |
Why?
|
| Nitroprusside | 7 | 1994 | 272 | 0.080 |
Why?
|
| Anabolic Agents | 1 | 2011 | 256 | 0.080 |
Why?
|
| Thrombosis | 1 | 2002 | 2956 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 6537 | 0.080 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2008 | 27 | 0.080 |
Why?
|
| Extracellular Fluid | 1 | 2009 | 165 | 0.080 |
Why?
|
| Creatine Kinase | 2 | 2012 | 685 | 0.080 |
Why?
|
| Hemoglobins | 2 | 2015 | 1532 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2017 | 2131 | 0.080 |
Why?
|
| Cardiac Output, Low | 3 | 1996 | 191 | 0.070 |
Why?
|
| Vascular Resistance | 5 | 2005 | 941 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 619 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 3682 | 0.070 |
Why?
|
| Retrospective Studies | 21 | 2015 | 81834 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2005 | 213 | 0.070 |
Why?
|
| Apoptosis | 4 | 2009 | 9526 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2012 | 906 | 0.070 |
Why?
|
| Chronic Disease | 7 | 2009 | 9382 | 0.070 |
Why?
|
| Aged | 40 | 2017 | 171520 | 0.070 |
Why?
|
| Endothelins | 1 | 2007 | 127 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 3111 | 0.070 |
Why?
|
| Societies, Medical | 4 | 2023 | 3955 | 0.070 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 518 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 2411 | 0.070 |
Why?
|
| Oxygen | 2 | 2002 | 4269 | 0.070 |
Why?
|
| American Heart Association | 2 | 2023 | 1049 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 3 | 1994 | 350 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2012 | 1165 | 0.070 |
Why?
|
| Chest Pain | 3 | 2012 | 1099 | 0.070 |
Why?
|
| Patient Selection | 3 | 2013 | 4266 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.070 |
Why?
|
| Nicardipine | 3 | 1991 | 60 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2007 | 10358 | 0.070 |
Why?
|
| Presenilin-1 | 1 | 2010 | 669 | 0.060 |
Why?
|
| Lung Diseases | 2 | 1997 | 1926 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2206 | 0.060 |
Why?
|
| Comorbidity | 6 | 2015 | 10601 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2006 | 277 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1196 | 0.060 |
Why?
|
| Lymphoma, B-Cell | 1 | 1992 | 945 | 0.060 |
Why?
|
| Dipyridamole | 1 | 2005 | 143 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 6551 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 1995 | 1310 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3922 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2023 | 2666 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2012 | 1608 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1990 | 1142 | 0.060 |
Why?
|
| Postoperative Complications | 6 | 2002 | 15880 | 0.060 |
Why?
|
| Hospital Charges | 3 | 2002 | 351 | 0.060 |
Why?
|
| Pregnancy | 4 | 2011 | 30179 | 0.060 |
Why?
|
| Renin-Angiotensin System | 1 | 2009 | 735 | 0.060 |
Why?
|
| Boston | 6 | 2015 | 9361 | 0.060 |
Why?
|
| Coronary Vasospasm | 1 | 2005 | 81 | 0.060 |
Why?
|
| Cardiomyoplasty | 1 | 2004 | 5 | 0.060 |
Why?
|
| Sodium | 1 | 2009 | 1595 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2010 | 1795 | 0.060 |
Why?
|
| Elasticity | 2 | 2005 | 658 | 0.060 |
Why?
|
| Recurrence | 4 | 2018 | 8510 | 0.060 |
Why?
|
| Kidney Transplantation | 2 | 1997 | 4285 | 0.060 |
Why?
|
| Risk Factors | 11 | 2015 | 74915 | 0.060 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1997 | 311 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2014 | 2929 | 0.050 |
Why?
|
| Migraine Disorders | 2 | 2013 | 1713 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2014 | 1518 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 8051 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2002 | 122 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 1995 | 2399 | 0.050 |
Why?
|
| Diagnostic Errors | 2 | 2009 | 1282 | 0.050 |
Why?
|
| Myocardial Ischemia | 4 | 2009 | 2139 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 1998 | 362 | 0.050 |
Why?
|
| Azathioprine | 4 | 2008 | 354 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 1885 | 0.050 |
Why?
|
| Piperazines | 2 | 2005 | 2546 | 0.050 |
Why?
|
| Blood Pressure | 9 | 2007 | 8538 | 0.050 |
Why?
|
| Systole | 6 | 1998 | 938 | 0.050 |
Why?
|
| Stroke | 4 | 2013 | 9791 | 0.050 |
Why?
|
| Heart Arrest | 2 | 2007 | 1516 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3063 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3794 | 0.050 |
Why?
|
| Incidence | 6 | 2015 | 21552 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2009 | 1197 | 0.050 |
Why?
|
| Pyridoxine | 1 | 2002 | 109 | 0.050 |
Why?
|
| Pericarditis, Constrictive | 2 | 1996 | 46 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3629 | 0.050 |
Why?
|
| DNA, Antisense | 1 | 2002 | 44 | 0.050 |
Why?
|
| Outpatients | 1 | 2010 | 1607 | 0.050 |
Why?
|
| Disease Progression | 3 | 2014 | 13655 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2010 | 15965 | 0.050 |
Why?
|
| Pulmonary Artery | 4 | 2005 | 1949 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 2001 | 1998 | 0.050 |
Why?
|
| Developing Countries | 1 | 2014 | 2901 | 0.050 |
Why?
|
| Survival Analysis | 5 | 2006 | 10125 | 0.050 |
Why?
|
| Headache | 1 | 2009 | 1260 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2002 | 271 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 2 | 2002 | 983 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2005 | 682 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2010 | 1473 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2002 | 149 | 0.050 |
Why?
|
| Clozapine | 1 | 2005 | 508 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2008 | 2229 | 0.050 |
Why?
|
| Lung | 3 | 2017 | 10090 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2291 | 0.050 |
Why?
|
| Cohort Studies | 8 | 2014 | 41797 | 0.050 |
Why?
|
| Ventriculography, First-Pass | 2 | 2003 | 20 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5152 | 0.050 |
Why?
|
| Phenotype | 3 | 2014 | 16712 | 0.040 |
Why?
|
| Japan | 1 | 2005 | 1418 | 0.040 |
Why?
|
| Quinolines | 2 | 1998 | 769 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14728 | 0.040 |
Why?
|
| Withholding Treatment | 2 | 2008 | 621 | 0.040 |
Why?
|
| Predictive Value of Tests | 7 | 2017 | 15460 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 1414 | 0.040 |
Why?
|
| Hospitals, General | 2 | 2015 | 807 | 0.040 |
Why?
|
| Myocardial Stunning | 1 | 2000 | 67 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1266 | 0.040 |
Why?
|
| Length of Stay | 4 | 2002 | 6521 | 0.040 |
Why?
|
| Cytochromes | 1 | 1999 | 18 | 0.040 |
Why?
|
| Cardiology Service, Hospital | 1 | 2001 | 241 | 0.040 |
Why?
|
| Electroconvulsive Therapy | 1 | 1985 | 502 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 1998 | 5162 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 2 | 2002 | 1085 | 0.040 |
Why?
|
| Homocysteine | 1 | 2002 | 637 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2000 | 20762 | 0.040 |
Why?
|
| Health Services Misuse | 1 | 2001 | 249 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2005 | 986 | 0.040 |
Why?
|
| Complement Activation | 1 | 2001 | 448 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 20231 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 666 | 0.040 |
Why?
|
| Mediastinum | 1 | 2000 | 273 | 0.040 |
Why?
|
| Proteomics | 1 | 2012 | 3901 | 0.040 |
Why?
|
| Prospective Studies | 11 | 2017 | 54914 | 0.040 |
Why?
|
| Patient Readmission | 3 | 2001 | 3308 | 0.040 |
Why?
|
| New York | 4 | 2002 | 882 | 0.040 |
Why?
|
| Inpatients | 1 | 2010 | 2561 | 0.040 |
Why?
|
| Euthanasia, Passive | 1 | 1999 | 64 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 1995 | 775 | 0.040 |
Why?
|
| United States | 8 | 2023 | 73121 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2001 | 621 | 0.040 |
Why?
|
| Methylprednisolone | 2 | 1999 | 387 | 0.040 |
Why?
|
| Jurisprudence | 1 | 1999 | 109 | 0.040 |
Why?
|
| Radiography | 1 | 2009 | 6995 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 1995 | 9263 | 0.040 |
Why?
|
| Norepinephrine | 2 | 1998 | 900 | 0.040 |
Why?
|
| Vasodilation | 1 | 2002 | 968 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 3816 | 0.040 |
Why?
|
| Respiration | 2 | 2017 | 1667 | 0.040 |
Why?
|
| Cadaver | 1 | 2002 | 1362 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2001 | 739 | 0.040 |
Why?
|
| Maximal Voluntary Ventilation | 1 | 1997 | 14 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2000 | 295 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 1999 | 236 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4622 | 0.040 |
Why?
|
| Ventricular Remodeling | 2 | 2010 | 1280 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2002 | 1724 | 0.040 |
Why?
|
| Dissent and Disputes | 1 | 1999 | 150 | 0.040 |
Why?
|
| Administration, Inhalation | 4 | 2005 | 1170 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2002 | 2286 | 0.040 |
Why?
|
| Medical Futility | 1 | 1999 | 136 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2019 | 236 | 0.040 |
Why?
|
| Group Processes | 1 | 1999 | 228 | 0.040 |
Why?
|
| Gene Expression | 4 | 2023 | 7605 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2005 | 1409 | 0.040 |
Why?
|
| Ventricular Dysfunction | 1 | 2018 | 144 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 2483 | 0.040 |
Why?
|
| Life Support Care | 1 | 1999 | 226 | 0.040 |
Why?
|
| Capillaries | 2 | 2014 | 756 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2002 | 1158 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11930 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2863 | 0.030 |
Why?
|
| Coronary Circulation | 3 | 1998 | 1617 | 0.030 |
Why?
|
| Survivors | 1 | 2007 | 2381 | 0.030 |
Why?
|
| Radioimmunodetection | 1 | 1996 | 45 | 0.030 |
Why?
|
| Respiratory Muscles | 1 | 1997 | 144 | 0.030 |
Why?
|
| Prednisone | 4 | 1999 | 1568 | 0.030 |
Why?
|
| Age Distribution | 1 | 2002 | 2881 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 1999 | 271 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2001 | 672 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1999 | 292 | 0.030 |
Why?
|
| Artifacts | 1 | 2005 | 1927 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1992 | 4362 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 552 | 0.030 |
Why?
|
| Caspases | 1 | 1999 | 884 | 0.030 |
Why?
|
| Renal Artery Obstruction | 1 | 1997 | 218 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1995 | 372 | 0.030 |
Why?
|
| Folic Acid | 1 | 2002 | 1336 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2002 | 164 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1998 | 849 | 0.030 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 1995 | 54 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 1996 | 207 | 0.030 |
Why?
|
| Coronary Artery Bypass | 2 | 2002 | 2194 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1995 | 305 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6008 | 0.030 |
Why?
|
| Specialization | 1 | 2020 | 782 | 0.030 |
Why?
|
| Radionuclide Angiography | 1 | 1994 | 23 | 0.030 |
Why?
|
| Information Systems | 1 | 1997 | 397 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 2 | 2002 | 1813 | 0.030 |
Why?
|
| Life Tables | 1 | 1995 | 368 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2008 | 132 | 0.030 |
Why?
|
| Heart Function Tests | 2 | 1998 | 318 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2006 | 3805 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2017 | 8730 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 18048 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2000 | 959 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1287 | 0.030 |
Why?
|
| Adolescent | 10 | 2006 | 89168 | 0.030 |
Why?
|
| Health Resources | 1 | 2000 | 950 | 0.030 |
Why?
|
| Embolism, Paradoxical | 1 | 2013 | 55 | 0.030 |
Why?
|
| Myocardial Reperfusion | 1 | 2014 | 339 | 0.030 |
Why?
|
| Body Image | 1 | 1998 | 644 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2014 | 192 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 1996 | 419 | 0.030 |
Why?
|
| Drug Therapy, Combination | 4 | 2005 | 6320 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1209 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 1999 | 12561 | 0.030 |
Why?
|
| Observer Variation | 2 | 2015 | 2622 | 0.030 |
Why?
|
| Heart Aneurysm | 1 | 1993 | 114 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 125 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2009 | 732 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2002 | 2377 | 0.030 |
Why?
|
| Heart Block | 1 | 1994 | 390 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 1998 | 645 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 616 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 231 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 1985 | 3738 | 0.020 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2014 | 284 | 0.020 |
Why?
|
| Hospital Mortality | 3 | 2002 | 5371 | 0.020 |
Why?
|
| Politics | 1 | 1999 | 821 | 0.020 |
Why?
|
| Cytarabine | 1 | 2014 | 697 | 0.020 |
Why?
|
| Echocardiography, Doppler | 2 | 2011 | 899 | 0.020 |
Why?
|
| Animals | 7 | 2013 | 169418 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2002 | 278 | 0.020 |
Why?
|
| Lisinopril | 1 | 2011 | 60 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1995 | 2258 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 3077 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 23638 | 0.020 |
Why?
|
| Sulfones | 2 | 2005 | 448 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 826 | 0.020 |
Why?
|
| Medicaid | 2 | 2001 | 2843 | 0.020 |
Why?
|
| Pharyngitis | 1 | 2012 | 222 | 0.020 |
Why?
|
| Furosemide | 1 | 2011 | 171 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 1999 | 2170 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2001 | 7863 | 0.020 |
Why?
|
| Registries | 3 | 2012 | 8373 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 1134 | 0.020 |
Why?
|
| Purines | 2 | 2005 | 614 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 1434 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3234 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1650 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 293 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 647 | 0.020 |
Why?
|
| Presenilin-2 | 1 | 2010 | 100 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 1993 | 346 | 0.020 |
Why?
|
| Stomach | 1 | 2014 | 703 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3207 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2014 | 558 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4362 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 1996 | 22293 | 0.020 |
Why?
|
| Isoenzymes | 2 | 2002 | 1685 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2001 | 2513 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2009 | 119 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 998 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1608 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2009 | 185 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1995 | 1176 | 0.020 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 59680 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2009 | 198 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2013 | 878 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11138 | 0.020 |
Why?
|
| Prevalence | 3 | 2010 | 15880 | 0.020 |
Why?
|
| Exercise | 2 | 1998 | 5940 | 0.020 |
Why?
|
| Family | 1 | 1999 | 3208 | 0.020 |
Why?
|
| Troponin T | 1 | 2012 | 787 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 1997 | 2028 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12096 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1479 | 0.020 |
Why?
|
| Cardiac Output | 2 | 2005 | 838 | 0.020 |
Why?
|
| Calcium | 3 | 2010 | 5793 | 0.020 |
Why?
|
| Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 1990 | 537 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1991 | 1056 | 0.020 |
Why?
|
| Fatigue | 1 | 2014 | 1556 | 0.020 |
Why?
|
| Kidney | 1 | 2002 | 7064 | 0.020 |
Why?
|
| Vasoconstriction | 2 | 2002 | 594 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4586 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 2005 | 2228 | 0.020 |
Why?
|
| Graft Survival | 1 | 1997 | 3890 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4425 | 0.020 |
Why?
|
| Gallium Radioisotopes | 1 | 2006 | 195 | 0.020 |
Why?
|
| Curriculum | 1 | 2019 | 3778 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 600 | 0.020 |
Why?
|
| Social Class | 1 | 2014 | 2000 | 0.020 |
Why?
|
| Hypertension | 2 | 1997 | 8611 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2012 | 1092 | 0.020 |
Why?
|
| Risk | 1 | 1997 | 9642 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13708 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4572 | 0.010 |
Why?
|
| Decision Making | 1 | 1999 | 3961 | 0.010 |
Why?
|
| Amyloid | 1 | 2010 | 852 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 2002 | 3594 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 809 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1683 | 0.010 |
Why?
|
| Rats | 3 | 2012 | 23839 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2014 | 5995 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2004 | 195 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1993 | 1333 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7449 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1985 | 414 | 0.010 |
Why?
|
| Antibodies | 2 | 2006 | 2425 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9687 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 1972 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2005 | 564 | 0.010 |
Why?
|
| Poverty | 1 | 2014 | 2719 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 2768 | 0.010 |
Why?
|
| Zimeldine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2006 | 6242 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3530 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 1891 | 0.010 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 1992 | 44 | 0.010 |
Why?
|
| Cause of Death | 1 | 1993 | 3727 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 9507 | 0.010 |
Why?
|
| Complement C5b | 1 | 2001 | 9 | 0.010 |
Why?
|
| Zebrafish | 1 | 2013 | 3038 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 1930 | 0.010 |
Why?
|
| Bronchiectasis | 1 | 2003 | 139 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2002 | 210 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2910 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 519 | 0.010 |
Why?
|
| Complement C5 | 1 | 2001 | 104 | 0.010 |
Why?
|
| Child | 3 | 2006 | 80863 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1990 | 2568 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12428 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2477 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2342 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13324 | 0.010 |
Why?
|
| Complement C4 | 1 | 2001 | 216 | 0.010 |
Why?
|
| Critical Care | 1 | 1993 | 2717 | 0.010 |
Why?
|
| Physicians | 1 | 1999 | 4615 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2002 | 19041 | 0.010 |
Why?
|
| Therapeutics | 1 | 2001 | 113 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3417 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5042 | 0.010 |
Why?
|
| Young Adult | 3 | 2012 | 60045 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 1421 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3672 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2604 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4138 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3253 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 2001 | 176 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17647 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2005 | 2079 | 0.010 |
Why?
|
| U937 Cells | 1 | 1999 | 260 | 0.010 |
Why?
|
| Ethics Committees | 1 | 1999 | 51 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 13047 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2014 | 4840 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 2076 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 14766 | 0.010 |
Why?
|
| Ethics Committees, Clinical | 1 | 1999 | 56 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1999 | 1816 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 4545 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1998 | 221 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1998 | 239 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1525 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1998 | 398 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1098 | 0.010 |
Why?
|
| Survival | 1 | 1998 | 161 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2003 | 1727 | 0.010 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 353 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2000 | 407 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1996 | 64 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 206 | 0.010 |
Why?
|
| Heart-Lung Transplantation | 1 | 1997 | 87 | 0.010 |
Why?
|
| Terminally Ill | 1 | 1999 | 240 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1997 | 207 | 0.010 |
Why?
|
| Liver | 1 | 1992 | 7575 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 3891 | 0.010 |
Why?
|
| Mutation | 2 | 2012 | 30243 | 0.010 |
Why?
|
| Communication | 2 | 2002 | 3910 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 257 | 0.010 |
Why?
|
| Massachusetts | 2 | 2000 | 8908 | 0.010 |
Why?
|
| Regression Analysis | 2 | 1997 | 6353 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1998 | 629 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1998 | 1123 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5709 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1998 | 903 | 0.010 |
Why?
|
| Professional-Family Relations | 1 | 1999 | 501 | 0.010 |
Why?
|
| Angioplasty | 1 | 1997 | 357 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1379 | 0.010 |
Why?
|
| Microcirculation | 1 | 1998 | 1282 | 0.010 |
Why?
|
| Health Services Research | 1 | 2001 | 1815 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2696 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2002 | 4834 | 0.010 |
Why?
|
| Infant | 1 | 1995 | 36497 | 0.010 |
Why?
|
| Adenosine | 1 | 1998 | 816 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1995 | 42623 | 0.010 |
Why?
|
| Pyrazines | 1 | 1998 | 1206 | 0.010 |
Why?
|
| Catheterization | 1 | 1998 | 1431 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1996 | 1585 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1990 | 10273 | 0.010 |
Why?
|
| Income | 1 | 2001 | 1878 | 0.010 |
Why?
|
| Coronary Care Units | 1 | 1993 | 235 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 4941 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1994 | 744 | 0.010 |
Why?
|
| Atrial Function, Right | 1 | 1991 | 32 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1915 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1996 | 821 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 82045 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 16029 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1990 | 40 | 0.010 |
Why?
|
| Necrosis | 1 | 1994 | 1621 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1997 | 1162 | 0.000 |
Why?
|
| Blood Volume | 1 | 1990 | 546 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1988 | 398 | 0.000 |
Why?
|
| Patient Discharge | 1 | 2001 | 3471 | 0.000 |
Why?
|
| Lactates | 1 | 1988 | 401 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3438 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1991 | 1697 | 0.000 |
Why?
|
| DNA Damage | 1 | 1996 | 2461 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1672 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1990 | 808 | 0.000 |
Why?
|
| Pressure | 1 | 1989 | 1173 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 27438 | 0.000 |
Why?
|
| Hospitals | 1 | 1999 | 3906 | 0.000 |
Why?
|
| Rest | 1 | 1990 | 952 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1990 | 2611 | 0.000 |
Why?
|
| Age Factors | 1 | 1998 | 18478 | 0.000 |
Why?
|
| Critical Illness | 1 | 1993 | 2754 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 9066 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 10784 | 0.000 |
Why?
|